Bayer reaches $80 million PCB contamination settlement with Ohio By Reuters

[ad_1]

© Reuters. FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay

By Tom Hals

(Reuters) – Bayer AG (DE:) reached an $80 million settlement with Ohio to resolve environmental damage allegedly caused by polychlorinated biphenyls, or PCBs, made by the company’s Monsanto (NYSE:) business, the state attorney general said on Thursday.

The funds from the German company, which did not admit liability, will be used for environmental cleanup, the attorney general said.

Monsanto, which Bayer (OTC:) acquired for $63 billion in 2018, never manufactured PCBs in Ohio or discharged them into Ohio waterways, Bayer said in a statement.

PCBs were once used widely to insulate electrical equipment, and were used in carbonless copy paper, caulking, floor finish and paint. They were outlawed by the U.S. government in 1979 after being linked to cancer.

Bayer has been trying to resolve a number of lawsuits related to Monsanto’s PCBs, which were used in commercial products from 1935 until 1977, when Monsanto voluntarily ceased production.

In addition to reaching legal settlements with states, the company reached a $648 million proposed class action settlement with about 2,500 cities and other local governments eligible as members of the class. Last week the agreement received preliminary approval from a federal judge.

Class members must decide whether to support the deal, object to the terms or opt out and pursue their own case, as the city of Los Angeles did earlier this month.

Bayer can withdraw from the settlement if more than 2% of the class members opt out.

Bayer also faces personal injury cases stemming from PCB exposure.

Two separate juries last year awarded a combined $247 million in damages stemming from exposure in a school in Washington state. Bayer said the evidence showed the plaintiffs were not exposed to unsafe levels of PCBs and the company said it planned to appeal both verdicts. (This story corrects paragraphs 5 and 6 to show there are about 2,500 members eligible for the class action, not thousands of separate lawsuits)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

[ad_2]

Source link

© Reuters. FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay

By Tom Hals

(Reuters) – Bayer AG (DE:) reached an $80 million settlement with Ohio to resolve environmental damage allegedly caused by polychlorinated biphenyls, or PCBs, made by the company’s Monsanto (NYSE:) business, the state attorney general said on Thursday.

The funds from the German company, which did not admit liability, will be used for environmental cleanup, the attorney general said.

Monsanto, which Bayer (OTC:) acquired for $63 billion in 2018, never manufactured PCBs in Ohio or discharged them into Ohio waterways, Bayer said in a statement.

PCBs were once used widely to insulate electrical equipment, and were used in carbonless copy paper, caulking, floor finish and paint. They were outlawed by the U.S. government in 1979 after being linked to cancer.

Bayer has been trying to resolve a number of lawsuits related to Monsanto’s PCBs, which were used in commercial products from 1935 until 1977, when Monsanto voluntarily ceased production.

In addition to reaching legal settlements with states, the company reached a $648 million proposed class action settlement with about 2,500 cities and other local governments eligible as members of the class. Last week the agreement received preliminary approval from a federal judge.

Class members must decide whether to support the deal, object to the terms or opt out and pursue their own case, as the city of Los Angeles did earlier this month.

Bayer can withdraw from the settlement if more than 2% of the class members opt out.

Bayer also faces personal injury cases stemming from PCB exposure.

Two separate juries last year awarded a combined $247 million in damages stemming from exposure in a school in Washington state. Bayer said the evidence showed the plaintiffs were not exposed to unsafe levels of PCBs and the company said it planned to appeal both verdicts. (This story corrects paragraphs 5 and 6 to show there are about 2,500 members eligible for the class action, not thousands of separate lawsuits)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add a Comment

Your email address will not be published. Required fields are marked *